Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by steadfaston Jul 22, 2014 8:02am

242 Views

Post# 22768538

3 months ago to-day

A NR was issued Cell Pouch with insulin-producing islets is safe and biocompatible
in patients. We must be getting closer to some indication of efficacy. Hopefully,
Dr Shapiro's guidelines have been met the past three months. If nopoos expectations
of results by Sept is still on track we are about 6 weeks away.
.

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles